4//SEC Filing
BUTITTA CYNTHIA M 4
Accession 0001209191-20-059510
CIK 0001750284other
Filed
Nov 18, 7:00 PM ET
Accepted
Nov 19, 6:42 PM ET
Size
11.8 KB
Accession
0001209191-20-059510
Insider Transaction Report
Form 4
BUTITTA CYNTHIA M
Director
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2020-09-16−83,876→ 0 totalExercise: $4.41Exp: 2030-08-11→ Common Stock (83,876 underlying) - Exercise/Conversion
Common Stock
2020-09-16$4.41/sh+83,876$369,558→ 83,876 total - Award
Stock Option (Right to Buy)
2020-08-12+83,876→ 83,876 totalExercise: $4.41Exp: 2030-08-11→ Common Stock (83,876 underlying) - Award
Stock Option (Right to Buy)
2020-11-18+21,520→ 21,520 totalExercise: $19.00Exp: 2030-11-17→ Common Stock (21,520 underlying)
Footnotes (2)
- [F1]The shares subject to the option vest in a series of 36 successive equal monthly installments measured from August 12, 2020, subject to the Reporting Person's continuous service through each applicable vesting date. The stock option is early exercisable.
- [F2]The shares subject to the option vest in a series of 12 successive equal monthy installments measured from June 1, 2020, subject to the Reporting Person's continuous service through each applicable vesting date. Such shares vest in full on the date of the Issuer's next annual meeting of stockholders if such stock option is not otherwise fully vested by such date, subject to the Reporting Person's continuous service through such vesting date.
Documents
Issuer
Olema Pharmaceuticals, Inc.
CIK 0001750284
Entity typeother
Related Parties
1- filerCIK 0001222082
Filing Metadata
- Form type
- 4
- Filed
- Nov 18, 7:00 PM ET
- Accepted
- Nov 19, 6:42 PM ET
- Size
- 11.8 KB